trending Market Intelligence /marketintelligence/en/news-insights/trending/wVkRvhVMUE-unt7IlxR0Vg2 content esgSubNav
In This List

BerGenBio completes 400M Norwegian kroner IPO

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


BerGenBio completes 400M Norwegian kroner IPO

BerGenBio ASA completed its IPO of 16 million new shares priced at 25 Norwegian kroner apiece on the Oslo Stock Exchange, raising gross proceeds of 400 million kroner.

BerGenBio will have a market capitalization of 1.24 billion kroner following the offering. The company will have 49,742,200 outstanding shares following the issuance of the new shares.

The net proceeds from the offering, along with existing cash resources, will be used to finance the completion of the company's clinical trials, research and development and general corporate activities.

Further, joint global coordinators ABG Sundal Collier, Arctic Securities and DNB Markets have exercised an option for an additional 1 million shares, bringing the total number of shares issued to 17 million.

As of April 5, US$1 was equivalent to 8.60 Norwegian kroner.